1. Home
  2. ›
  3. Videos
  4. ›
  5. Dermbits
Dermbits

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions

Dr Dorizas on Actinic Keratosis (October 2026)

What has led you to consider tirbanibulin earlier in AK management rather than reserving field therapy for patients with more extensive disease?
Oct 1, 2026Actinic Keratosis

What has led you to consider tirbanibulin earlier in AK management rather than reserving field therapy for patients with more extensive disease?

-

Have younger patients presented different priorities or concerns around field therapy that have influenced your decision to use tirbanibulin?
Oct 1, 2026Actinic Keratosis

Have younger patients presented different priorities or concerns around field therapy that have influenced your decision to use tirbanibulin?

-

Can you describe a patient who was reluctant to undergo field therapy again after a difficult previous experience and how tirbanibulin affected your treatment approach?
Oct 1, 2026Actinic Keratosis

Can you describe a patient who was reluctant to undergo field therapy again after a difficult previous experience and how tirbanibulin affected your treatment approach?

-

What should clinicians know about cash-pay or network pharmacy pathways for Medicare patients who have been prescribed tirbanibulin?
Oct 1, 2026Actinic Keratosis

What should clinicians know about cash-pay or network pharmacy pathways for Medicare patients who have been prescribed tirbanibulin?

-

What do you try to understand when a patient who would benefit from field therapy is reluctant to move forward with treatment?
Oct 1, 2026Actinic Keratosis

What do you try to understand when a patient who would benefit from field therapy is reluctant to move forward with treatment?

-

What tends to cause clinicians or patients to fall into a reactive pattern of treating AKs as they appear rather than developing a longer-term management strategy?
Oct 1, 2026Actinic Keratosis

What tends to cause clinicians or patients to fall into a reactive pattern of treating AKs as they appear rather than developing a longer-term management strategy?

-

CME & EducationAbout Us
Loading profile...
  • Conditions & Treatments

  • Learn from the Experts

  • Support Your Practice

  • Conferences & Highlights
  • CME Activities
  • Educational Resources
  • Community Resources

  • Our Expert Network
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Helpful Links

Terms of Service

Editorial & Medical Review Policy

Privacy Policy

Cookie Policy

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2026 dermsquared | All Rights Reserved